35178738|t|Imaging Net Retrograde Axonal Transport In Vivo: A Physiological Biomarker.
35178738|a|OBJECTIVE: The objective of this study is to develop a novel method for monitoring the integrity of motor neurons in vivo by quantifying net retrograde axonal transport. METHODS: The method uses single photon emission computed tomography to quantify retrograde transport to spinal cord of tetanus toxin fragment C (125 I-TTC) following intramuscular injection. We characterized the transport profiles in 3 transgenic mouse models carrying amyotrophic lateral sclerosis (ALS)-associated genes, aging mice, and SOD1G93A transgenic mice following CRISPR/Cas9 gene editing. Lastly, we studied the effect of prior immunization of tetanus toxoid on the transport profile of TTC. RESULTS: This technique defines a quantitative profile of net retrograde axonal transport of TTC in living mice. The profile is distinctly abnormal in transgenic SOD1G93A mice as young as 65 days (presymptomatic) and worsens with disease progression. Moreover, this method detects a distinct therapeutic benefit of gene editing in transgenic SOD1G93A mice well before other clinical parameters (eg, grip strength) show improvement. Symptomatic transgenic PFN1C71G/C71G ALS mice display gross reductions in net retrograde axonal transport, which is also disturbed in asymptomatic mice harboring a human C9ORF72 transgene with an expanded GGGGCC repeat motif. In wild-type mice, net retrograde axonal transport declines with aging. Lastly, prior immunization with tetanus toxoid does not preclude use of this assay. INTERPRETATION: This assay of net retrograde axonal transport has broad potential clinical applications and should be particularly valuable as a physiological biomarker that permits early detection of benefit from potential therapies for motor neuron diseases. ANN NEUROL 2022;91:716-729.
35178738	391	400	125 I-TTC	Chemical	-
35178738	493	498	mouse	Species	10090
35178738	515	544	amyotrophic lateral sclerosis	Disease	MESH:D000690
35178738	546	549	ALS	Disease	MESH:D000690
35178738	575	579	mice	Species	10090
35178738	605	609	mice	Species	10090
35178738	701	715	tetanus toxoid	Species	
35178738	744	747	TTC	Chemical	-
35178738	842	845	TTC	Chemical	-
35178738	856	860	mice	Species	10090
35178738	920	924	mice	Species	10090
35178738	1091	1099	SOD1G93A	CellLine	CVCL:C0CZ
35178738	1100	1104	mice	Species	10090
35178738	1213	1217	C71G	DNAMutation	tmVar:c|SUB|C|71|G;HGVS:c.71C>G;VariantGroup:0;CorrespondingGene:203228;CorrespondingSpecies:9606
35178738	1218	1221	ALS	Disease	MESH:D000690
35178738	1222	1226	mice	Species	10090
35178738	1328	1332	mice	Species	10090
35178738	1345	1350	human	Species	9606
35178738	1351	1358	C9ORF72	Gene	203228
35178738	1420	1424	mice	Species	10090
35178738	1801	1822	motor neuron diseases	Disease	MESH:D016472
35178738	Association	MESH:D000690	203228
35178738	Association	HGVS:c.71C>G;CorrespondingGene:203228	MESH:D000690
35178738	Association	MESH:D000690	203228

